Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Genetic testing for Progressive Cardiac Conduction Disease (PCCD) (R328)

Progressive cardiac conduction disease (PCCD) can manifest as sinoatrial exit block, atrioventricular block, infra-Hisian block, or bundle branch block.

Background information

Impaired conduction can be caused by ion channel defects that alter action potential shape or by defective coupling between cardiomyocytes. This disorder is genetically heterogeneous and the clinical sensitivity of this panel is unknown.

The genes included may also indicate a syndromic disorder which includes conduction abnormalities as part of the clinical presentation.

Currently there are eleven genes on the panel: DES, EMD, GLA, HCN4, LAMP2, LMNA, NKX2-5, PRKAG2, SCN5A, TNNI3K and TTR.

NHSE funded test referrals should meet the relevant NHSE eligibility criteria (pdf).

Testing strategy

Clinically affected probands:

R328 - Singleton analysis of a small panel of genes.

Targeted analysis for known / previously reported familial variants:

  • Family testing in clinically unaffected family members at risk of inheriting a previously reported familial pathogenic variant (R242)
  • Diagnostic confirmation in individuals at risk of inheriting a previously reported familial pathogenic variant and clinically suspected of having the familial condition (R240)
  • Segregation studies in affected family members to aid variant interpretation (R375)
  • Prenatal diagnosis for families with a pathogenic or likely pathogenic variant identified (R240 and R321 Maternal cell contamination)

Target reporting times

  • 84 calendar days for diagnostic screening of affected individuals
  • 42 calendar days for diagnostic confirmation in individuals at risk of inheriting a previously reported familial pathogenic variant and clinically suspected of having the familial condition (R240)
  • 14 calendar days for presymptomatic testing of clinically unaffected family members at risk of inheriting a previously reported familial pathogenic variant (R242)

Turnaround times for genetic / genomic testing

Speciment requirements and referring samples

All non NHSE referrals should be accompanied by a completed referral form.

Requesting specialties:

  • Cardiology
  • Clinical Genetics
  • Paediatrics
  • Electrophysiology
  • Pathology
  • Coroners

Specimen requirements and referring samples

Price list for non NHSE referrals (pdf)

Contact us

Oxford Genetics Laboratories - Contact us

Specific enquiries

Email: OxfordCardiac@nhs.net

Last reviewed:02 August 2021